Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot tr...
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
About this item
Full title
Author / Creator
Eskandary, Farsad , Dürr, Michael , Budde, Klemens , Doberer, Konstantin , Reindl-Schwaighofer, Roman , Waiser, Johannes , Wahrmann, Markus , Regele, Heinz , Spittler, Andreas , Lachmann, Nils , Firbas, Christa , Mühlbacher, Jakob , Bond, Gregor , Halloran, Philipp F. , Chong, Edward , Jilma, Bernd and Böhmig, Georg A.
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Late antibody-mediated rejection (ABMR) triggered by donor-specific antibodies (DSA) is a cardinal cause of kidney allograft dysfunction and loss. Diagnostic criteria for this rejection type are well established, but effective treatment remains a major challenge. Recent randomized controlled trials (RCT) have failed to demonstrate the efficacy of w...
Alternative Titles
Full title
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f9f9861b28ea4b8fb1fe6e6eb9d5070c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9f9861b28ea4b8fb1fe6e6eb9d5070c
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-018-3158-6
